440 related articles for article (PubMed ID: 25850036)
1. Targeting Cdc20 as a novel cancer therapeutic strategy.
Wang L; Zhang J; Wan L; Zhou X; Wang Z; Wei W
Pharmacol Ther; 2015 Jul; 151():141-51. PubMed ID: 25850036
[TBL] [Abstract][Full Text] [Related]
2. Cdc20: a potential novel therapeutic target for cancer treatment.
Wang Z; Wan L; Zhong J; Inuzuka H; Liu P; Sarkar FH; Wei W
Curr Pharm Des; 2013; 19(18):3210-4. PubMed ID: 23151139
[TBL] [Abstract][Full Text] [Related]
3. Targeting Cdc20 for cancer therapy.
Jeong SM; Bui QT; Kwak M; Lee JY; Lee PC
Biochim Biophys Acta Rev Cancer; 2022 Nov; 1877(6):188824. PubMed ID: 36243246
[TBL] [Abstract][Full Text] [Related]
4. APC/C ubiquitin ligase: Functions and mechanisms in tumorigenesis.
Schrock MS; Stromberg BR; Scarberry L; Summers MK
Semin Cancer Biol; 2020 Dec; 67(Pt 2):80-91. PubMed ID: 32165320
[TBL] [Abstract][Full Text] [Related]
5. Peptide inhibitors of the anaphase promoting-complex that cause sensitivity to microtubule poison.
Schuyler SC; Wu YO; Chen HY; Ding YS; Lin CJ; Chu YT; Chen TC; Liao L; Tsai WW; Huang A; Wang LI; Liao TW; Jhuo JH; Cheng V
PLoS One; 2018; 13(6):e0198930. PubMed ID: 29883473
[TBL] [Abstract][Full Text] [Related]
6. Cdc20 directs proteasome-mediated degradation of the tumor suppressor SMAR1 in higher grades of cancer through the anaphase promoting complex.
Paul D; Ghorai S; Dinesh US; Shetty P; Chattopadhyay S; Santra MK
Cell Death Dis; 2017 Jun; 8(6):e2882. PubMed ID: 28617439
[TBL] [Abstract][Full Text] [Related]
7. The master cell cycle regulator APC-Cdc20 regulates ciliary length and disassembly of the primary cilium.
Wang W; Wu T; Kirschner MW
Elife; 2014 Aug; 3():e03083. PubMed ID: 25139956
[TBL] [Abstract][Full Text] [Related]
8. Cdc20 inhibitor apcin inhibits the growth and invasion of osteosarcoma cells.
Gao Y; Zhang B; Wang Y; Shang G
Oncol Rep; 2018 Aug; 40(2):841-848. PubMed ID: 29901174
[TBL] [Abstract][Full Text] [Related]
9. APC(Cdc20) suppresses apoptosis through targeting Bim for ubiquitination and destruction.
Wan L; Tan M; Yang J; Inuzuka H; Dai X; Wu T; Liu J; Shaik S; Chen G; Deng J; Malumbres M; Letai A; Kirschner MW; Sun Y; Wei W
Dev Cell; 2014 May; 29(4):377-91. PubMed ID: 24871945
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer-associated mutation in SPOP impairs its ability to target Cdc20 for poly-ubiquitination and degradation.
Wu F; Dai X; Gan W; Wan L; Li M; Mitsiades N; Wei W; Ding Q; Zhang J
Cancer Lett; 2017 Jan; 385():207-214. PubMed ID: 27780719
[TBL] [Abstract][Full Text] [Related]
11. Inhibiting the anaphase promoting complex/cyclosome induces a metaphase arrest and cell death in multiple myeloma cells.
Lub S; Maes A; Maes K; De Veirman K; De Bruyne E; Menu E; Fostier K; Kassambara A; Moreaux J; Hose D; Leleu X; King RW; Vanderkerken K; Van Valckenborgh E
Oncotarget; 2016 Jan; 7(4):4062-76. PubMed ID: 26716651
[TBL] [Abstract][Full Text] [Related]
12. Quantitative framework for ordered degradation of APC/C substrates.
Lu D; Girard JR; Li W; Mizrak A; Morgan DO
BMC Biol; 2015 Nov; 13():96. PubMed ID: 26573515
[TBL] [Abstract][Full Text] [Related]
13. Cdc20 proteolysis requires p38 MAPK signaling and Cdh1-independent APC/C ubiquitination during spindle assembly checkpoint activation by cadmium.
Yen AH; Yang JL
J Cell Physiol; 2010 May; 223(2):327-34. PubMed ID: 20054826
[TBL] [Abstract][Full Text] [Related]
14. Substrate recognition by the Cdc20 and Cdh1 components of the anaphase-promoting complex.
Pfleger CM; Lee E; Kirschner MW
Genes Dev; 2001 Sep; 15(18):2396-407. PubMed ID: 11562349
[TBL] [Abstract][Full Text] [Related]
15. Identification of the APC/C co-factor FZR1 as a novel therapeutic target for multiple myeloma.
Crawford LJ; Anderson G; Johnston CK; Irvine AE
Oncotarget; 2016 Oct; 7(43):70481-70493. PubMed ID: 27655696
[TBL] [Abstract][Full Text] [Related]
16. Cdc20: At the Crossroads between Chromosome Segregation and Mitotic Exit.
Kapanidou M; Curtis NL; Bolanos-Garcia VM
Trends Biochem Sci; 2017 Mar; 42(3):193-205. PubMed ID: 28202332
[TBL] [Abstract][Full Text] [Related]
17. The KEN box: an APC recognition signal distinct from the D box targeted by Cdh1.
Pfleger CM; Kirschner MW
Genes Dev; 2000 Mar; 14(6):655-65. PubMed ID: 10733526
[TBL] [Abstract][Full Text] [Related]
18. Cdh1 is an antagonist of the spindle assembly checkpoint.
Nagai M; Ushimaru T
Cell Signal; 2014 Oct; 26(10):2217-22. PubMed ID: 25025567
[TBL] [Abstract][Full Text] [Related]
19. Parkin Regulates Mitosis and Genomic Stability through Cdc20/Cdh1.
Lee SB; Kim JJ; Nam HJ; Gao B; Yin P; Qin B; Yi SY; Ham H; Evans D; Kim SH; Zhang J; Deng M; Liu T; Zhang H; Billadeau DD; Wang L; Giaime E; Shen J; Pang YP; Jen J; van Deursen JM; Lou Z
Mol Cell; 2015 Oct; 60(1):21-34. PubMed ID: 26387737
[TBL] [Abstract][Full Text] [Related]
20. Mitotic regulation of the APC activator proteins CDC20 and CDH1.
Kramer ER; Scheuringer N; Podtelejnikov AV; Mann M; Peters JM
Mol Biol Cell; 2000 May; 11(5):1555-69. PubMed ID: 10793135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
